Molecular Assemblies
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9880 Campus Point Dr Ste 110, San Diego,...Phone Number
(858) 257-3078Website
www.molecularassemblies.comRevenue
$7.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Molecular Assemblies
Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company's patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. Molecular Assemblies' technology will enable the reading and writing of DNA for many industries, including industrial synthetic biology and precision medicine, as well as emerging applications of DNA for data information storage, nanomachines, and bio-based electronics. Molecular Assemblies is headquartered in San Diego.Explore more
Molecular Assemblies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Molecular Assemblies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Molecular Assemblies is spiking on competitors!
Funding: Get notified immidiatlly once Molecular Assemblies has new funding data
Product Launch: Get notified when Molecular Assemblies launches new products
Website visits: Recent activity has been detected on your website
Click to see if Molecular Assemblies had a recent Job posting/layoffs
Molecular Assemblies, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Molecular Assemblies recently announced quarterly report
Check if Molecular Assemblies has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Molecular Assemblies
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Molecular Assemblies
Find 2 more new buyers
Compare Similar Companies to Molecular Assemblies
Compare insights from companies similar to Molecular Assemblies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Molecular Assemblies is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Molecular Assemblies is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Molecular Assemblies.
Molecular Assemblies financials insights
Gather financial insights about Molecular Assemblies, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Private Equity
$4.5M
Angel/Seed
$2.3M
2020
Debt
$150K
2021
Debt
$325K
Series A
$24M
2022
Series B
$25.8M
Molecular Assemblies Tech Stack
A closer look at the technologies used by Molecular Assemblies
Most Recent Scoops
Hiring Plans
Molecular Assemblies is hiring in Engineering & Technical for the first time in 12 months.
Hiring Plans
Event
Events
Event
Events
Promotion
Executive Move
Molecular Assemblies has announced that Phil Paik has been promoted from Development Vice President, Platform to the role of Chief Technology Officer.
New Hire
Executive Move
Molecular Assemblies News & Media
Molecular Assemblies Achieves Key Milestones in DARPA NOW Project for On-Demand DNA Vaccine Manufacturing
● Molecular Assemblies awarded an additional $4 million to support further technology development in next phase of DARPA-funded project being led by GE HealthCare's Technology and Innovation Center ● Molecular Assemblies' Fully Enzymatic Synthesis enables synthesis of long, accurate...Molecular Assemblies Launches Partner Program for Onsite Synthesis of Long, Pure, Accurate DNA
Company also announced the availability of 400mer oligonucleotides for early ordering SAN DIEGO, May 7, 2024 /PRNewswire/ -- Molecular Assemblies, Inc., ("MAI" or the "Company") a pioneer and leader in the field of enzymatic DNA synthesis, today announced the launch of its Partnering...Molecular Assemblies Announces the Appointment of Two Industry Leaders to Its Commercial-Technology Advisory Board
Board member, Todd C. Peterson, Ph.D., serves as Chair of the CTAB New appointments include David Smoller, Ph.D., serial entrepreneur and General Partner at Cultivation Capital Life Sciences and Stephen Turner, Ph.D., Founder at PacBio SAN DIEGO, Feb. 13, 2024 /PRNewswire/ -- Molecular...Molecular Assemblies Receives the 2023 BioServices Innovation of the Year Award from BioTech Breakthrough Awards Program
Molecular Assemblies, pioneer of its Fully Enzymatic SynthesisTM (FESTM) technology to provide researchers long, pure, and accurate DNA oligonucleotides is focused on removing today's limitations for life science and biotechnology research. SAN DIEGO, Nov. 8, 2023 /PRNewswire/ --...
Read more news
Top Business Services Companies
Frequently Asked Questions Regarding Molecular Assemblies
Sign Up For FreeTo access detailed company insights
Molecular Assemblies, Inc. is a private life sciences company developing an enzymatic DNA synthesis technology designed to power the next generation of DNA-based products. The company's patented enzymatic method, based on making DNA the way nature makes DNA, produces long, high quality, sequence-specific DNA reliably, affordably, and sustainably. M... Read More
